These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12435451)

  • 1. Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds.
    Borstnik K; Paik IH; Shapiro TA; Posner GH
    Int J Parasitol; 2002 Dec; 32(13):1661-7. PubMed ID: 12435451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action.
    Jefford CW
    Curr Med Chem; 2001 Dec; 8(15):1803-26. PubMed ID: 11772352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial activity of yingzhaosu A analogues.
    Kim HS; Begum K; Ogura N; Wataya Y; Tokuyasu T; Masuyama A; Nojima M; McCullough KJ
    J Med Chem; 2002 Oct; 45(21):4732-6. PubMed ID: 12361400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
    Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I
    Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.
    O'Neill PM
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1117-28. PubMed ID: 16144496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
    Rudrapal M; Chetia D
    Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides.
    Posner GH; O'Neill PM
    Acc Chem Res; 2004 Jun; 37(6):397-404. PubMed ID: 15196049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.
    Bachi MD; Korshin EE; Hoos R; Szpilman AM; Ploypradith P; Xie S; Shapiro TA; Posner GH
    J Med Chem; 2003 Jun; 46(12):2516-33. PubMed ID: 12773055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.
    Grigorov M; Weber J; Tronchet JM; Jefford CW; Milhous WK; Maric D
    J Chem Inf Comput Sci; 1997; 37(1):124-30. PubMed ID: 9025258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in synthetic peroxidic drugs as artemisinin mimics.
    Jefford CW
    Drug Discov Today; 2007 Jun; 12(11-12):487-95. PubMed ID: 17532534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity.
    Hofheinz W; Bürgin H; Gocke E; Jaquet C; Masciadri R; Schmid G; Stohler H; Urwyler H
    Trop Med Parasitol; 1994 Sep; 45(3):261-5. PubMed ID: 7899801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria: new chemotherapeutic peroxide drugs.
    Borstnik K; Paik IH; Posner GH
    Mini Rev Med Chem; 2002 Dec; 2(6):573-83. PubMed ID: 12370042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.
    Meshnick SR; Taylor TE; Kamchonwongpaisan S
    Microbiol Rev; 1996 Jun; 60(2):301-15. PubMed ID: 8801435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an antimalarial synthetic trioxolane drug development candidate.
    Vennerstrom JL; Arbe-Barnes S; Brun R; Charman SA; Chiu FC; Chollet J; Dong Y; Dorn A; Hunziker D; Matile H; McIntosh K; Padmanilayam M; Santo Tomas J; Scheurer C; Scorneaux B; Tang Y; Urwyler H; Wittlin S; Charman WN
    Nature; 2004 Aug; 430(7002):900-4. PubMed ID: 15318224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mode of action of antimalarial endoperoxides.
    Meshnick SR
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S31-2. PubMed ID: 8053021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
    Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
    J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials.
    Peters W; Fleck SL; Robinson BL; Stewart LB; Jefford CW
    Ann Trop Med Parasitol; 2002 Sep; 96(6):559-73. PubMed ID: 12396319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
    Patel OPS; Beteck RM; Legoabe LJ
    Eur J Med Chem; 2021 Mar; 213():113193. PubMed ID: 33508479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme as trigger and target for trioxane-containing antimalarial drugs.
    Meunier B; Robert A
    Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.